• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON AND JOHNSON VISION CARE, INC. - IRELAND 1-DAY ACUVUE® DEFINE¿ WITH LACREON®; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON AND JOHNSON VISION CARE, INC. - IRELAND 1-DAY ACUVUE® DEFINE¿ WITH LACREON®; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number 1DL
Device Problem No Apparent Adverse Event (3189)
Patient Problems Conjunctivitis (1784); Unspecified Infection (1930); Irritation (1941); Itching Sensation (1943); Keratitis (1944); Red Eye(s) (2038)
Event Date 05/09/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).(b)(6).
 
Event Description
On 09may2017 a patient (pt) called our affiliate in (b)(4) to report that while wearing the 1-day acuvue define brand contact lenses he/she experienced right eye redness and itching.The pt reported on insertion of the suspect lens, the pt noted a stinging sensation.The suspect lens was removed.The pt stated that he/she had an appointment with the eye care provider (ecp) (b)(6)2017 for evaluation.On 10may2017 the pt called and additional information was provided: pt reports diagnosis of keratitis and conjunctivitis and was prescribed tarivid eye drop, flumetholon ophthalmic suspension 0.1, and hamerone a eye drop 4 times a day; pt reports follow-up appointment and will provide an update.The pt reported that he/she had an additional follow-up visit on (b)(6) 2017 and provided additional information: pt reported that the eye is still red and will follow-up with the ecp again next week.No additional medication was prescribed.Pt reported he/she was advised not to return to contact lens wear ¿up to 3 weeks after the eye is fully recovered.¿ the pt reported a follow-up appointment on (b)(6) 2017 and provided additional information: pt reports that the eye is still red and was advised by the ecp to continue to use the same eye drops until the return visit for an eye check again later in the week.On 22may2017 the pt reported a follow-up visit with the ecp on (b)(6) 2017 and advised the ecp indicated the treatment was completed for the ¿infection.¿ pt reported that the eye is still a bit red and the ecp advised that ¿part of the blood vessel had been expanded, cause red eye, which is incurable.¿ pt reported that he/she could not provide the medical record.On 22may2017 a return call was placed to the pt and additional information was obtained as follows: pt reported that he/she had ¿conjunctivitis and keratitis together.¿ the pt also reported that he/she tried the affected lens on the left eye and had the ¿same symptoms¿ but indicated that the ¿left eye was not serious.¿ the left eye was also affected on the (b)(6) 2017.On (b)(6) 2017 the pt reported that he/she tried trial lenses for acuvue oasys 1-day without issue.No additional medical information has been received and no additional medical information is expected.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 3325240762 was produced under normal conditions.The suspect product was requested for return, but it has not yet been received.This submission is for the pts os event.The od event will be submitted in a separate report.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1-DAY ACUVUE® DEFINE¿ WITH LACREON®
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON AND JOHNSON VISION CARE, INC. - IRELAND
one technological park plassey
limerick
EI 
Manufacturer Contact
rose harrell
7500 centurion park blvd.
jacksonville, FL 32256
9044433364
MDR Report Key6641840
MDR Text Key77610919
Report Number9617710-2017-05012
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
Reporter Country CodeKN
PMA/PMN Number
N18033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Other
Type of Report Initial
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/01/2021
Device Catalogue Number1DL
Device Lot Number3325240762
Was Device Available for Evaluation? No
Date Manufacturer Received05/22/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/22/2016
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-